default author photo

Frank Griesinger

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

3

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

First-Line Nivolumab Plus Ipilimumab in Pleural Mesothelioma: Efficacy and Safety Data from the Real-World MesoNet Study

Number of pages: 14 Posted: 02 Jun 2025
Rajiv Shah, Eva L. Buchmeier, Hans-Georg Kopp, Daniel C. Christoph, Frank Griesinger, Martin Reck, Petra Hoffknecht, Jonas Kuon, Nikolaj Frost, Christian Grohe, Martin Faehling, Jingting Luan, Julia Roeper, Paolo Chesi, Miriam Blasi, Martin Kimmich, Till Olchers, Helge Bischoff, Laura Klotz, Inn Chung, Petros Christopoulos and Michael Thomas
affiliation not provided to SSRN, University of Witten/Herdecke - Kliniken der Stadt Köln gGmbH, Robert Bosch Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, German Centre for Lung Research - Lungen Clinic Grosshansdorf, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Klinikum Esslingen, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Robert Bosch Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Heidelberg University, affiliation not provided to SSRN, Heidelberg University and Heidelberg University
Downloads 36 (1,236,159)

Abstract:

Loading...

mesothelioma, Immunotherapy, First-line, retrospective cohort, epithelioid

2.

Real-World Evidence of the Impact of Guideline Concordance on Survival in Non-Small Cell Lung Cancer

Number of pages: 25 Posted: 12 Jun 2025
Thomas Elter, Ursula Marschall, Patrizia Maria Maier, Claudia Grellmann, Matthias Arnold, Carolin Groß-Ophoff-Müller, David Hoier and Frank Griesinger
affiliation not provided to SSRN, BARMER, affiliation not provided to SSRN, affiliation not provided to SSRN, inav, affiliation not provided to SSRN, University Hospital Zurich and affiliation not provided to SSRN
Downloads 31 (1,304,549)

Abstract:

Loading...

lung cander, NSCLC, guideline concordant care, survival benefit, certified cancer centers, health insurance claims data

3.

Institutional Variability in Testing for Actionable Genetic Alterations in Patients with Stage IIIB/C or IV Non-Small Cell Lung Cancer: A Real-World Study from the German Prospective, Observational, Multicenter CRISP Registry (AIO-TRK-0315)

Number of pages: 19 Posted: 20 Oct 2025
Friederike C. Althoff, Horst-Dieter Hummel, Konrad Kokowski, Corinna Elender, Christian Grah, Stefan Zacharias, Annette Fleitz, Martina Jänicke, Annika Groth, Paula Ludwig, Arnd Nusch, Marcel Reiser, Henning Pelz, Jörg Wiegand, Frank Griesinger, Michael Thomas, Wilfried E. E. Eberhardt and Martin Sebastian
Goethe University Frankfurt - University Hospital Frankfurt, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Heidelberg University, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 30 (1,318,317)

Abstract:

Loading...

Non-small cell lung cancer (NSCLC)Metastatic diseaseMolecular testingPrecision oncology Institutional variabilityPractice patternsAccess to careReal-world data